Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open Label, Observational, Non-interventional Study for the Evaluation of Remission Rates in Patients With MDD Under Treatment With Various Anti-depressives

NCT00770289 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT00770289
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00770289 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open Label, Observational, Non-interventional Study for the Evaluation of Remission Rates in Patients With MDD Under Treatment With Various Anti-depressives
Lead sponsor
Pfizer
Phase
Observational
Overall status
Completed
Start date
May 31, 2008
Completion date
December 31, 2009
Enrollment
851 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

major depressive disorder